Cell Reprogramming Services
Since the invention of induced pluripotent stem cells (iPSCs) in 2006 by a research team led by Japanese scientist Shinya Yamanaka, iPSCs have significantly changed the landscape of stem cell research and drug development.
Creative Bioarray is committed to providing multiple viable and cost-effective strategies for iPSC reprogramming. Our reprogramming technology allows us to obtain high-quality iPSCs in a short period of time from a variety of cell samples and rigorously test their pluripotency and differentiation potential, with a success rate of more than 90%. In addition, the direct lineage reprogramming technology we established allows for the direct reprogramming of specialized cells into another cell type. We provide abundant cell reprogramming services to help researchers obtain the required cell types to meet their scientific research needs.
We developed simple, repeatable, and noninvasive strategies to reprogram cells present in urine into iPSC or other cell types.
We offer a systematic workflow to provide our clients with reprogramming of blood-derived cells, including iPSC generation and differentiation to specific cell types.
Skin cell reprogramming is of great significance for tissue repair and drug screening. We have developed various advanced strategies to provide customers with skin cell reprogramming services.
We provide neuron reprogramming and glial cell reprogramming services. Our efficient services will help customers accelerate their research process.
We are committed to producing iPSCs from domesticated animals to provide unrestricted cell resources for veterinary and preclinical treatment tools.
We provide one-stop cell reprogramming services, including helping customers improve the efficiency of reprogramming through a variety of strategies, such as the development of new delivery systems.
We have developed multiple methods to characterize iPSCs. With years of exploration in iPSC development, we are confident to provide several characterization services for iPSC pluripotency to our customers worldwide.
Service Workflow
For Research Use Only. Not For Clinical Use.
